GVBL.BO | GENOMIC VALLEY BIOTECH LIMITED Annual &

Annual Income Statements

(In INR)

Breakdown	2024	2023	2022	2021	2020
Revenue	1.65 Million	27.22 Million	705.64 Thousand	2.08 Million	8.46 Million
Cost of Revenue	-	15.85 Million	24.49 Thousand	1.3 Million	153.92 Thousand
Gross Profit	1.65 Million	11.36 Million	681.15 Thousand	779.04 Thousand	8.31 Million
Operating Expenses	375 Thousand	5.3 Million	1.05 Million	4.01 Million	4.78 Million
Selling, General and Administrative Expenses	375 Thousand	1.53 Million	1.96 Million	1.04 Million	1.8 Million
Research and Development Expenses	-	-	-	-	-
Other Expenses	-	-	-	-	-
Cost and Expenses	375 Thousand	21.15 Million	1.07 Million	5.31 Million	4.93 Million
Operating Income	1.27 Million	8.7 Million	-4.56 Million	-3.23 Million	3.83 Million
Interest Expense	-	-	-	-	-
Income Tax Expense	339.00	6080.00	76.91 Thousand	572.37 Thousand	802.61 Thousand
Earnings before Tax	151.47 Thousand	6.48 Million	-16.49 Thousand	-5.01 Million	2.05 Million
Net Income	151.81 Thousand	6.48 Million	-93.4 Thousand	-5.59 Million	2.85 Million
Earnings Per Share Basic	0.05	2.12	-0.03	-1.83	0.94
Earnings Per Share Diluted	0.05	2.12	-0.03	-1.83	0.94
Weighted Average Shares Outstanding	3.03 Million	3.05 Million	3.11 Million	3.05 Million	3.04 Million
Weighted Average Shares Outstanding (Diluted)	3.03 Million	3.05 Million	3.11 Million	3.05 Million	3.04 Million
Gross Margin	1.00	0.42	0.97	0.37	0.98
EBIT Margin	0.09	0.32	-5.28	-0.64	0.66
Profit Margin	0.09	0.24	-0.13	-2.69	0.34
EBITDA	147.4 Thousand	8.78 Million	-3.72 Million	-1.34 Million	5.62 Million
Earnings Before Tax Margin	0.77	0.32	-6.47	-1.55	0.45

Breakdown	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2	2023 Q1
Revenue	1.55 Million	-	1.65 Million	390 Thousand	675.25 Thousand	585.5 Thousand
Cost of Revenue	-	-	-	-	-	-
Gross Profit	1.55 Million	-	1.65 Million	390 Thousand	675.25 Thousand	585.5 Thousand
Operating Expenses	277.44 Thousand	446.33 Thousand	1.49 Million	172.43 Thousand	443.11 Thousand	317.39 Thousand
Selling, General and Administrative Expenses	120 Thousand	45 Thousand	-	45 Thousand	90 Thousand	195 Thousand
Research and Development Expenses	-	-	-	-	-	-
Other Expenses	-	-	-	-	-	-
Cost and Expenses	277.44 Thousand	446.33 Thousand	1.49 Million	172.43 Thousand	443.11 Thousand	317.39 Thousand
Operating Income	1.27 Million	-446.33 Thousand	136.47 Thousand	217.56 Thousand	232.13 Thousand	253.1 Thousand
Interest Expense	-	-	-	-	-	-
Income Tax Expense	-	339.00	339.00	-	-	-
Earnings before Tax	1.27 Million	-446.33 Thousand	151.47 Thousand	217.56 Thousand	232.13 Thousand	268.1 Thousand
Net Income	1.27 Million	-445.99 Thousand	151.81 Thousand	217.56 Thousand	232.13 Thousand	268.1 Thousand
Earnings Per Share Basic	0.42	-0.15	-	0.07	0.08	0.09
Earnings Per Share Diluted	0.42	-0.15	-	0.07	0.08	0.09
Weighted Average Shares Outstanding	3.03 Million	2.97 Million	3.03 Million	3.1 Million	2.9 Million	2.97 Million
Weighted Average Shares Outstanding (Diluted)	3.03 Million	2.97 Million	3.03 Million	3.1 Million	2.9 Million	2.97 Million
Gross Margin	1.00	-	1.00	1.00	1.00	1.00
EBIT Margin	0.82	-	-	0.61	0.35	0.47
Profit Margin	0.82	-	0.09	0.56	0.34	0.46
EBITDA	1.27 Million	-443.6 Thousand	-	237.37 Thousand	234.87 Thousand	272.91 Thousand
Earnings Before Tax Margin	0.82	-	0.08	0.56	0.34	0.43